Lihop, Mercy S.

HRN: 23-35-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
CEFTRIAXONE 1G (VIAL)
07/17/2023
07/23/2023
IV
2g
Od
Uti
Waiting Final Action 
07/25/2023
MUPIROCIN 2%, 15G (TUBE)
07/25/2023
07/25/2023
TOPICAL
2%
Prepare 3pcs For Bedside Use
Nasal Polyp
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: